Epivax Oncology Company

Epivax Oncology is a providence, RI and NY-based precision cancer immunotherapy company.
Technology: Peptides and Proteins
Industry: Peptides and Proteins
Headquarters: Providence, Rhode Island, United States
Founded Date: 2017-01-01
Employees Number: 1-10
Investors Number: 5
Total Funding: 33000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-06-12
Last Funding Type: Venture - Series Unknown

Visit Website
http://twitter.com/GenerexBiotech
Register and Claim Ownership